SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Parentheticals (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Deferred Financing Costs {1}
Amortization of deferred financing costs related to convertible debt	$ 0	$ 4,835
Research and Development
Clinical Studies expenses - fees, charges and related expenses	776,000	1,306,000
Stock Based Compensation
Compensation expenses recorded	460,924	125,983
Common shares from outstanding warrants	66,652,108	65,539,827
Common shares from convertible debentures and related accrued interest	14,456,371	11,674,402
Advertising Costs
Advertising costs are charged to operations when incurred	0	0
Concentrations of Credit Risk
Company maintains cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation ("FDIC") limit.	$ 250,000	$ 0